Skip to main content
Livermore
Livermore
ZHEN

Baird Financial Group, Inc.

SEC CIK
0001648711
Latest filing
Aug 12, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Baird Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
1,450,388
Value
$131.6M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by Baird Financial Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,450,388$131.6M0.2%−283,527−16.4%ReducedHolders
Q1 20261,733,915$178.0M0.3%−262,068−13.1%ReducedHolders
Q4 20251,995,983$250.1M0.4%−12,219−0.6%ReducedHolders
Q3 20252,008,202$269.0M0.4%+16,152+0.8%AddedHolders
Q2 20251,992,050$270.9M0.5%+12,764+0.6%AddedHolders
Q1 20251,979,286$262.6M0.5%+54,778+2.8%AddedHolders
Q4 20241,924,508$217.7M0.4%−19,799−1.0%ReducedHolders
Q3 20241,944,307$221.7M0.4%−106,967−5.2%ReducedHolders
Q2 20242,051,274$213.1M0.4%+21,365+1.1%AddedHolders
Q1 20242,029,909$230.7M0.5%−2,515−0.1%ReducedHolders
Q4 20232,032,424$223.7M0.5%+297,789+17.2%AddedHolders
Q3 20231,734,635$168.0M0.5%−16,959−1.0%ReducedHolders
Q2 20231,751,594$191.0M0.5%−297,424−14.5%ReducedHolders
Q1 20232,049,018$207.5M0.5%+39,970+2.0%AddedHolders
Q4 20222,009,048$220.6M0.6%+2010.0%AddedHolders
Q3 20222,008,847$194.4M0.6%−36,324−1.8%ReducedHolders
Q2 20222,045,171$222.2M0.6%+16,666+0.8%AddedHolders
Q1 20222,028,505$240.1M0.6%+18,316+0.9%AddedHolders
Q4 20212,010,189$282.9M0.7%−14,433−0.7%ReducedHolders
Q3 20212,024,622$239.2M0.6%−100,956−4.7%ReducedHolders
Q2 20212,125,578$246.4M0.6%+71,220+3.5%AddedHolders
Q1 20212,054,358$246.2M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.